CAMBR.CT.S

CAMBR.CT.S Share · GB00B8DV9647 · A1T9LW (XLON) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CAMBR.CT.S
No Price
Closing Price XLON 01.05.2026: 36,10 GBX
01.05.2026 09:02
Current Prices from CAMBR.CT.S
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
COG.L
GBX
01.05.2026 09:02
36,10 GBX
0,60 GBX
+1,69 %
Share Float & Liquidity
Free Float 54,90 %
Shares Float 25,56 M
Shares Outstanding 46,55 M
Company Profile for CAMBR.CT.S Share
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I–IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Company Data

Name CAMBR.CT.S
Company Cambridge Cognition Holdings Plc
Website https://www.cambridgecognition.com
Primary Exchange XLON London
WKN A1T9LW
ISIN GB00B8DV9647
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Trevor Robbins CBE, FBPsS, FMedSci, FRS,
Market Capitalization 17 Mio
Country United Kingdom
Currency GBP
Employees 0,1 T
Address Tunbridge Court, CB25 9TU Cambridge
IPO Date 2013-04-18

Stock Splits

Date Split
31.05.2024 10003:10000

Ticker Symbols

Name Symbol
Frankfurt 1M7.F
London COG.L
More Shares
Investors who hold CAMBR.CT.S also have the following shares in their portfolio:
CELLNEX TEL. 20/29 MTN
CELLNEX TEL. 20/29 MTN Bond
LANXESS AG 12/22 MTN
LANXESS AG 12/22 MTN Bond